Bosentan improves renal regional blood flow in rats with experimental congestive heart failure.
The effects of the mixed endothelin receptor antagonist bosentan on renal regional haemodynamics were investigated in rats with aorto-caval fistula, an experimental model of congestive heart failure. A matched group of normal rats served as control. Injection of bosentan (10 mg/kg i.v.) to the rats with decompensated congestive heart failure produced an increase in cortical (+20%) and medullary (+12%) blood flow, and a decrease in vascular resistance in the cortex (-30%) and medulla (-23%), while reducing mean arterial pressure by approximately 10 mm Hg. In rats with compensated congestive heart failure and in normal animals, infusion of bosentan did not affect blood pressure and cortical perfusion. These findings indicate that 1) endothelin receptor blockade produces beneficial effects on renal haemodynamics in rats with experimental congestive heart failure and 2) endothelin-1 may be involved in the pathogenesis of renal hypoperfusion only in decompensated congestive heart failure.
Gurbanov
K
K
Department of Physiology and Biophysics, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology Haifa.
Rubinstein
I
I
Hoffman
A
A
Abassi
Z
Z
Better
O S
OS
Winaver
J
J
D000818:Animals; D000077300:Bosentan; D004195:Disease Models, Animal; D006333:Heart Failure / Q000503:physiopathology*; D007668:Kidney / Q000098:blood supply; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D012039:Regional Blood Flow / Q000187:drug effects*; D013449:Sulfonamides / Q000494:pharmacology*
D013449:Sulfonamides; D000077300:Bosentan